Geneimmune Biotechnology Corp
Germantown, MD
- UEI
- TKVTR8LCJB33
- CAGE
- 64SK4
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 20501 Seneca Meadows Pkwy #300f, Germantown, MD 20876, USA
- Website
- geneimmuneusa.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| DNA prep 36542021 | National Institute of Allergy and Infectious Diseases | $12,223 | |
| For covid-19: for site-directed mutagenesis, gene synthesis, and plasmid prep | National Institute of Allergy and Infectious Diseases | $151,620 | |
| Gene synthesis, site-directed mutagenesis, plasmid prep QTY 200 | National Institute of Allergy and Infectious Diseases | $49,810 | |
| Other functions-site directed mutagenesis, subcloning, and DNA prep service | National Institute of Allergy and Infectious Diseases | $98,959 | |
| DNA prep | National Institute of Allergy and Infectious Diseases | $12,265 |
About Geneimmune Biotechnology Corp
Geneimmune Biotechnology Corp. is a biotechnology company based in Rockville, MD that specializes in a wide range of services including DNA cloning, gene mutagenesis, plasmid production, gene synthesis, protein production, and polyclonal antibody production. Through federal contract awards from the Department of Health and Human Services' National Institutes of Health, Geneimmune Biotechnology Corp. has provided various research and development services related to genetics, immunology, virology, and infectious diseases.
Specifically, Geneimmune Biotechnology Corp.'s federal contract awards have been for services such as site-directed mutagenesis, gene synthesis, plasmid preparation, DNA preparation, and subcloning for research on COVID-19 and other infectious diseases. These contracts have been prime contract awards from the National Institute of Allergy and Infectious Diseases, with no set-aside designations. Contract completion dates range from 2019 to 2023, and potential contract values range from $12,223 to $151,620. In summary, Geneimmune Biotechnology Corp. leverages its biotechnology capabilities to support federal infectious disease and immunology research through flexible research and development services provided via prime federal contracts.
Quick answers
What is Geneimmune Biotechnology Corp's UEI?
Geneimmune Biotechnology Corp's Unique Entity ID (UEI) in SAM.gov is TKVTR8LCJB33.
What is Geneimmune Biotechnology Corp's CAGE code?
Geneimmune Biotechnology Corp's CAGE code is 64SK4.
What is Geneimmune Biotechnology Corp's primary NAICS code?
Geneimmune Biotechnology Corp's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Geneimmune Biotechnology Corp located?
Geneimmune Biotechnology Corp's physical address in SAM.gov is 20501 Seneca Meadows Pkwy #300f, Germantown, MD 20876, USA.
Is Geneimmune Biotechnology Corp registered in SAM.gov?
Yes. Geneimmune Biotechnology Corp's SAM.gov registration is active through June 12, 2027.
What is Geneimmune Biotechnology Corp's most recent federal award?
Geneimmune Biotechnology Corp's most recent federal contract award is DNA prep 36542021 (75N93021P01388), from National Institute of Allergy and Infectious Diseases, on September 10, 2021.
On GovTribe
See Geneimmune Biotechnology Corp's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors